Showing results (1191-1200 of 1,974) with videos related to
Sort By:
Pageof 198
Experimental Neurology|November 1, 1990
Nigral dopamine type-1 receptors are reduced in Huntington's disease: a postmortem autoradiographic study using [3H]SCH 23390 and correlation with [3H]forskolin bindingF Filloux, M V Wagster, S Folstein, et al.British Journal of Cancer|July 4, 1998
Cisplatin dose rate as a risk factor for nephrotoxicity in childrenR Skinner, A D Pearson, M W English, et al.British Journal of Cancer|January 1, 1997
Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapyB Peng, M J Tilby, M W English, et al.British Journal of Cancer|January 8, 2004
Estimation of glomerular filtration rate in paediatric cancer patients using 51CR-EDTA population pharmacokineticsM Cole, L Price, A Parry, et al.American Journal of Physiology. Heart and Circulatory Physiology|September 18, 2004
Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunctionMasaharu Nakayama, Xinhua Yan, Robert L Price, et al.Journal of Neuropathology and Experimental Neurology|November 13, 2004
Neuropathologic criteria for diagnosing Alzheimer disease in persons with pure dementia of Alzheimer typeDaniel W McKeel, Joseph L Price, J Philip Miller, et al.JPEN. Journal of Parenteral and Enteral Nutrition|March 9, 2021
Body composition assessment after pediatric liver transplantAlissa D Perteet-Jackson, Carrie P Earthman, Kathleen L Price, et al.Frontiers in Microbiology|June 4, 2019
Fecal Microbial Communities in a Large Representative Cohort of California Dairy CowsJill V Hagey, Srijak Bhatnagar, Jennifer M Heguy, et al.The American Journal of Physiology|January 1, 1996
Exercise- and hypertension-induced collagen changes are related to left ventricular function in rat heartsM L Burgess, J Buggy, R L Price, et al.Neurology|March 1, 1996
Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's diseaseJ C Morris, M Storandt, D W McKeel, et al.Pageof 198